Proposed Directors of Tirupati Graphite explain why they have requisitioned an GM. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTissue Regenix Group Regulatory News (TRX)

Share Price Information for Tissue Regenix Group (TRX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 69.00
Bid: 68.00
Ask: 70.00
Change: 0.00 (0.00%)
Spread: 2.00 (2.941%)
Open: 69.00
High: 69.00
Low: 69.00
Prev. Close: 69.00
TRX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Management Appointments

26 Jul 2006 07:01

Torex Retail PLC26 July 2006 Torex Retail Plc ("the Company") Announces non-Board appointments for Operational Management to deliver Organic Growth Strategy & Further strengthening of Finance Function Torex Retail Plc, an international market leader in the provision of innovativeretail IT systems, announces that following the completion of its 2006acquisition strategy, the Company's operational management is to be restructuredinto five newly created Divisions in order to fully focus on maximising organicgrowth opportunities in the coming period. As a result, the following senior internal appointments have been made,reporting directly to the Plc Board: • CEO of UK General Retail: Doug Hargrove (age 39) (Previously Chief Operating Officer, UK & Ireland) • CEO of Overseas Business: Phil Cox (age 39) (Previously Group Treasury Officer) • CEO of Hospitality & QSR ('Quick Service Restaurants'): Keith Pascal (age 41) (Previously VP Sales & Marketing, Savista Inc.) • CEO of P&C ('Petroleum & Convenience'): Brendan Kavanagh (age 41) (Previously Head of P&C Division Worldwide) • CEO of Americas General Retail: Mike Hess (age 43) (Previously President & COO of Torex North America) The Company is also pleased to today announce the appointment of Marcus Leek asGroup Finance Director with immediate effect. Marcus (age 31) joins from 4uBusiness Ltd (a part of the Caudwell Group) where he held the position ofFinance Director. He also has considerable experience in the retail sectorhaving worked for J. Sainsbury plc and Bells Stores Limited in a variety ofsenior finance roles. Marcus is an industry trained Chartered Accountant. Reporting directly to Mark Pearman, Marcus will be responsible for all groupfinancial matters. Marcus will be part of the wider senior management team atTorex as well as playing a leading role in the finance function. He will alsoplay an active part in investor relations. Continuing Plc Finance Director and Business Development Director Mark Pearmancommented: "I am delighted that we have secured the services of Marcus. He is highlyqualified and his relevant industry experience and energy make him the choicecandidate; we expect him to make an immediate contribution to the Group". Supporting Marcus will be Mark Lovett (age 32) as UK Finance Director. Markjoins Torex Retail from Xansa plc, an IT and Business Process Outsourcingprovider, where for the past 12 months he was Finance Director for the Financialand Business services division. Prior to that, Mark was Financial Controller forthe Retail division, where he worked on new and existing contracts withretailers such as Boots, Tesco, B&Q and Marks & Spencer. Having trained as aChartered Accountant with KPMG, Mark subsequently held a number of financepositions with Misys plc in the UK, North America and Far East. On the new management appointments, Chairman and Chief Executive Chris Moorestated: "Following the completion of our recent acquisition strategy, we have nowachieved the sufficient scale necessary to compete globally. It was clear thatas we entered our next phase of organic-focused growth, we needed an experiencedmanagement team and structure that could successfully drive this strategythroughout the Group. The five new CEO appointments reflect this and will alsomake for a clearer reporting structure at Board level. It was also important for us to strengthen our internal finance function toreflect the new size of the Company. I am delighted to have secured thehigh-calibre services of Marcus Leek and Mark Lovett who join us with clearfinancial and industry focus in Retail and IT". Torex Retail Plc will announce interim results for the six months ended 30 June2006 on Monday, 14 August. As stated in the recent 11 July trading update,management expect these results to be slightly ahead of analyst's expectationsand remain confident for the full year. -Ends- Enquiries: Torex Retail PlcChris Moore, Chairman & Chief Executive +44 (0)870 300 6061 Citigate Dewe Rogerson +44 (0)20 7638 9571Seb Hoyle / Lucie Holloway This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
14th Feb 20137:00 amRNSSuccessful safety study of dCELL® Meniscus
11th Feb 20132:57 pmRNSDirectorate Change
9th Jan 20137:15 amRNSHolding(s) in Company
30th Nov 201211:21 amRNSTissue Regenix board changes
26th Nov 20127:00 amRNSSets up US subsidiary
19th Nov 20127:00 amRNSAdds new patent global licence portfolio
4th Oct 20127:00 amRNSInterim data from clinical trial of dCELL® Dermis
4th Oct 20127:00 amRNSHalf Yearly Report
1st Oct 201210:57 amRNSTissue Regenix - senior development appointment
28th Sep 20123:30 pmRNSNotice of Results
7th Sep 20127:00 amRNSdCELL(R) vascular patch is safe and effective
2nd Aug 20122:31 pmRNSTissue Regenix makes appointment to Cardiac team
31st Jul 20123:02 pmRNSDirector/PDMR Shareholding
19th Jun 20122:39 pmRNSHolding(s) in Company
14th Jun 20127:00 amRNSResearch Update
11th Jun 201212:35 pmRNSResult of AGM
25th May 20127:00 amRNSExpands scope of development activities with NHSBT
10th May 20127:00 amRNSFinal Results
19th Apr 20121:49 pmRNSPoster shown at SAWC
16th Apr 20123:18 pmRNSNotice of Results
7th Feb 20124:00 pmRNSIssue of Equity and Total Voting Rights
11th Jan 201211:36 amRNSHolding(s) in Company
6th Jan 20125:05 pmRNSHolding(s) in Company
3rd Jan 20125:45 pmRNSHolding(s) in Company
3rd Jan 20125:43 pmRNSHolding(s) in Company
3rd Jan 20128:49 amRNSHolding(s) in Company
28th Dec 201112:00 pmRNSResult of General Meeting
8th Dec 201112:53 pmRNSIssue of Equity
25th Nov 20112:23 pmRNSUniversity Partner wins Queen's Anniversary Prize
4th Nov 20112:16 pmRNSHolding(s) in Company
14th Oct 20112:33 pmRNSHolding(s) in Company
10th Oct 20117:00 amRNSHalf Yearly Report
26th Jul 201111:04 amRNSIssue of Equity
7th Jul 20113:52 pmRNSIssue of Share Options
5th Jul 20111:30 pmRNSIssue of Equity
22nd Jun 20118:35 amRNSReceives EUR280,000 Grant Funding
13th Jun 20117:00 amRNSDirectorate Appointment
3rd Jun 201110:02 amRNSAGM Statement
11th May 20117:00 amRNSPositive Results in Clinical Evaluation of dCELL
4th May 20117:00 amRNSFinal Results
21st Apr 20117:00 amRNSTissue Regenix enters commercialisation agreement
29th Mar 20117:00 amRNSDirectorate Change
10th Mar 20117:00 amRNSNotice of allowance of patent received
4th Jan 201111:27 amRNSHolding(s) in Company
30th Dec 20109:05 amRNSHolding(s) in Company
23rd Dec 201012:44 pmRNSChange of Adviser
21st Dec 201010:12 amRNSAdviser - Change of Name
16th Dec 20107:00 amRNSResearch Update
10th Dec 20109:20 amRNSChange of Adviser
26th Nov 20103:12 pmRNSChange of Registered Office

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.